Cargando…

Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy

Lung cancer is the leading cause of cancer mortality. As a heterogeneous disease, it has different subtypes and various treatment modalities. In addition to conventional surgery, radiotherapy and chemotherapy, targeted therapy and immunotherapy have also been applied in the clinics. However, drug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yifan, Cheng, Wenxu, Xin, HongYi, Liu, Ran, Wang, Qinqi, Cai, Wenqi, Peng, Xiaochun, Yang, Fuyuan, Xin, HongWu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042676/
https://www.ncbi.nlm.nih.gov/pubmed/37009262
http://dx.doi.org/10.1186/s12645-023-00174-x